Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Urol Oncol. 2015 Apr 20;33(6):267.e31–267.e37. doi: 10.1016/j.urolonc.2015.03.009

Table 1.

Patient Characteristics by Time Period and Expenditure Groups

N % Average Monthly Expenditure Per Patient

Total Patients 1807 - $88.33

Age Category

66 to 69 366 20.3% $100.79
70 to 74 526 29.1% $86.83
75 to 79 528 29.2% $86.28
>=80 387 21.4% $81.36
Race

White 1667 92.3% $88.58
Black 56 3.1% $77.32
Other 84 4.6% $90.65
Sex

Male 1176 65.1% $84.66
Female 631 34.9% $95.15
Marital Status

Married 585 32.4% $90.04
Unmarried/Unknown 1222 67.6% $87.50
Education Level*

<10% Did not Graduate HS 538 29.8% $92.48
10–19% Did not Graduate HS 773 42.8% $89.11
20–29% Did not Graduate HS 263 14.6% $84.55
>=30% Did not Graduate HS 182 10.1% $82.13
Unknown 51 2.8% $74.31
Zip Code Income

< $38,657 432 23.9% $85.49
$38,658–$47,921 436 24.1% $84.38
$47,922–$62,354 450 24.9% $85.44
>$62,354 438 24.2% $99.65
Unknown 51 2.8% $74.31
Comorbidity

0 1018 56.3% $88.94
1 503 27.8% $87.92
2 209 11.6% $79.82
3 77 4.3% $105.89
Final Stage of Disease

Stage 1 390 21.6% $74.09
Stage 2 317 17.5% $71.69
Stage 3 416 23.0% $91.89
Stage 4 395 21.9% $115.74
Unknown/No Cancer 289 16.0% $83.20
Nodal Status

All nodes negative 690 38.2% $74.81
Nodes Positive 248 13.7% $139.35
No Nodes Examined 869 48.1% $84.49
Chemotherapy Administered

No Chemotherapy 1173 64.9% $64.12
Neoadjuvant Only 98 5.4% $88.15
Adjuvant Only 226 12.5% $154.25
Neoadjuvant/Adjuvant 19 1.1% $168.62
Treatment Only 180 10.0% $105.54
Neoadjuvant/Adjuvant/Treatment 87 4.8% $147.22
Continuous 24 1.3% $245.36
Admission to Hospital after Initial Discharge

None 505 27.9% $62.79
1 Admission 435 24.1% $82.26
2 Admissions 328 18.2% $111.03
3 Admissions 539 29.8% $103.33